30 Participants Needed

Mediterranean Diet for Inflammation Post-Colonoscopy

SR
JA
Overseen ByJack A Gilbert, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you are on medications that require dietary restrictions or are for chronic diseases, you may not be eligible to participate.

What data supports the effectiveness of the Modified Plant-Based Mediterranean Diet treatment for reducing inflammation after a colonoscopy?

Research shows that following a Mediterranean diet, which is rich in antioxidants and has anti-inflammatory effects, can improve inflammatory markers in people with inflammatory bowel diseases. This suggests it might help reduce inflammation after a colonoscopy as well.12345

Is the Mediterranean Diet safe for humans?

The Mediterranean Diet has been studied in various conditions and is generally considered safe for humans. Studies have shown it can improve health markers and reduce inflammation without significant safety concerns.14567

How does the Mediterranean Diet treatment differ from other treatments for inflammation after a colonoscopy?

The Mediterranean Diet treatment is unique because it focuses on a plant-based diet rich in antioxidants and anti-inflammatory foods, which can help reduce inflammation by promoting beneficial gut bacteria. Unlike other treatments that might involve medication, this approach uses dietary changes to manage inflammation.14589

What is the purpose of this trial?

This study aims to investigate the impact of various healthy diets, specifically a modified plant-based Mediterranean diet, on the gut microbiome and overall well-being post-colonoscopy. The investigators hypothesize that certain diets can positively influence gut bacteria, reducing inflammation and enhancing metabolic signals.To explore this, they will utilize metagenomic testing on stool samples to analyze the DNA of gut microorganisms. Additionally, they will conduct immune profiling on serum samples and perform metabolomic analysis to comprehensively evaluate the diet-induced changes in immune response and metabolic pathways. This multi-faceted approach will help them understand how dietary changes affect the composition and function of the gut microbiome, immune function, and overall metabolism.

Eligibility Criteria

This trial is for individuals scheduled for their 2nd or 3rd colonoscopy who previously had certain types of polyps but currently do not have colorectal cancer. It's designed to see if a modified plant-based Mediterranean diet can improve gut health and reduce inflammation after the procedure.

Inclusion Criteria

I am due for my 2nd or 3rd colonoscopy and have had certain types of polyps but no current colon cancer.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Dietary Intervention

Participants follow a modified plant-based Mediterranean diet post-colonoscopy to reduce inflammation and improve gut microbiome composition.

4 weeks
Weekly stool collection, blood draws at Weeks 1, 4, 6, and 8

Follow-up

Participants are monitored for changes in inflammatory markers and gut microbiome composition.

4 weeks
Blood draws and stool samples collected at Weeks 6 and 8

Optional Long-term Follow-up

Optional follow-ups at 1, 3, and 5 years to assess polyp recurrence.

Treatment Details

Interventions

  • Modified Plant-Based Mediterranean Diet
Trial Overview The study tests how a modified plant-based Mediterranean diet affects the gut microbiome, immune system, and metabolism after a colonoscopy. Researchers will analyze stool DNA, blood serum, and metabolic changes to understand the diet's impact on health.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Dietary Intervention GroupExperimental Treatment1 Intervention
Participants in this arm will follow a modified plant-based Mediterranean diet following their colonoscopies. The dietary intervention aims to reduce inflammation and improve gut microbiome composition. Participants' gut bacteria and overall health will be monitored through blood and stool sample collections, focusing on inflammation reduction and metabolic health improvement.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Diego

Lead Sponsor

Trials
1,215
Recruited
1,593,000+

Seerave Foundation

Collaborator

Trials
1
Recruited
30+

Findings from Research

In a study of 153 patients with ulcerative colitis after pouch surgery, adherence to the Mediterranean diet (MED) was linked to lower levels of fecal calprotectin, a marker of intestinal inflammation, suggesting that MED may help reduce inflammation in inflammatory bowel diseases.
Patients with normal pouch function who adhered more closely to the MED showed a trend towards a lower risk of developing pouchitis over an 8-year follow-up, indicating potential long-term benefits of the diet.
Adherence to the Mediterranean diet is associated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery.Godny, L., Reshef, L., Pfeffer-Gik, T., et al.[2021]
In a study of 83,147 participants over 17 years, higher adherence to a modified Mediterranean diet was linked to a significantly lower risk of developing Crohn's disease (CD), with a hazard ratio of 0.42 for those with the highest adherence compared to the lowest.
No significant association was found between Mediterranean diet adherence and the risk of ulcerative colitis (UC), suggesting that the diet may specifically benefit those at risk for CD rather than UC.
Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn's disease: results from two large prospective cohort studies.Khalili, H., Håkansson, N., Chan, SS., et al.[2021]
Diet plays a significant role in the onset and severity of inflammatory bowel diseases (IBDs), as it can influence immune system regulation and intestinal health.
While enteral nutrition is effective for treating pediatric Crohn's disease, there is a lack of research on the impact of whole food dietary interventions, highlighting the need for further studies to explore dietary patterns and their potential in managing IBD.
Diet in Treatment of Inflammatory Bowel Diseases.Sasson, AN., Ananthakrishnan, AN., Raman, M.[2022]

References

Adherence to the Mediterranean diet is associated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery. [2021]
Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn's disease: results from two large prospective cohort studies. [2021]
Diet in Treatment of Inflammatory Bowel Diseases. [2022]
Management of Dietary Habits and Diarrhea in Fap Individuals: A Mediterranean Low-Inflammatory Dietary Intervention. [2021]
Adherence to the Mediterranean Diet Improved Clinical Scores and Inflammatory Markers in Children with Active Inflammatory Bowel Disease: A Randomized Trial. [2022]
A Mediterranean Diet Pattern Improves Intestinal Inflammation Concomitant with Reshaping of the Bacteriome in Ulcerative Colitis: A Randomised Controlled Trial. [2023]
A Pilot Low-Inflammatory Dietary Intervention to Reduce Inflammation and Improve Quality of Life in Patients With Familial Adenomatous Polyposis: Protocol Description and Preliminary Results. [2020]
Index-based dietary patterns and colorectal cancer risk: a systematic review. [2023]
Mediterranean Diet to Prevent the Development of Colon Diseases: A Meta-Analysis of Gut Microbiota Studies. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security